Fingerprint
Dive into the research topics of 'A phase 1 dose-escalation study of NEO-102 in patients with refractory colon and pancreatic cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase 1 dose-escalation study of NEO-102 in patients with refractory colon and pancreatic cancer
Muhammad S. Beg, Nilofer S. Azad, Sandip P. Patel, Jose Torrealba, Sharon Mavroukakis, Melony A. Beatson, Xue Ping Wang, Philip M. Arlen, Michael A. Morse
Research output: Contribution to journal › Article › peer-review
14
Scopus
citations